Anticoagulation halves mortality in severe COVID-19, study shows

A leading cardiologist says an RCT is needed, but he is already anticoagulating hospitalised patients unless contraindicated
Reuters Health Staff writer
vial of heparin and syringe

Among hospitalised adult COVID-19 patients, prophylactic and therapeutic anticoagulation are associated with much lower rates of intubation and death, a US retrospective study shows.

As reported in the Journal of the American College of Cardiology (JACC), doctors examined the association of anticoagulation with mortality, intubation and major bleeding in 4389 people with COVID-19 (median age 65 years, 44% women).